-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Titan Pharmaceuticals Inc quarterly/annual Earnings Per Share, Diluted history and growth rate from 2011 to 2023.
- Titan Pharmaceuticals Inc Earnings Per Share, Diluted for the quarter ending June 30, 2024 was -2.29 USD/shares, a 8.53% decline year-over-year.
- Titan Pharmaceuticals Inc Earnings Per Share, Diluted for the twelve months ending June 30, 2024 was -6.6 USD/shares, a 65.5% increase year-over-year.
- Titan Pharmaceuticals Inc annual Earnings Per Share, Diluted for 2023 was -7.41 USD/shares, a 51.2% increase from 2022.
- Titan Pharmaceuticals Inc annual Earnings Per Share, Diluted for 2022 was -15.2 USD/shares.
- Titan Pharmaceuticals Inc annual Earnings Per Share, Diluted for 2019 was -0.72 USD/shares, a 56.6% increase from 2018.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)